« Back to Record
Citation APA

Martinez Chanza, N., Xie, W., Issa, M., Dzimitrowicz, H., Tripathi, A., Beuselinck, B., Lam, E., Zakharia, Y., McKay, R., Shah, S., Mortazavi, A., Harrison, M., Sideris, S., Kaymakcalan, M. M., Abou Alaiwi, S., Nassar, A. A., Nuzzo, P. V., Hamid, A., Choueiri, T. T., & Harshman, L. L. (2020). Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: A retrospective international multicenter study. Journal for ImmunoTherapy of Cancer, 8(1), e000538. doi:10.1136/jitc-2020-000538


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/307210

Martinez Chanza, N., Xie, W., Issa, M., Dzimitrowicz, H., Tripathi, A., Beuselinck, B., Lam, E., Zakharia, Y., McKay, R., Shah, S., Mortazavi, A., Harrison, M., Sideris, S., Kaymakcalan, M. M., Abou Alaiwi, S., Nassar, A. A., Nuzzo, P. V., Hamid, A., Choueiri, T. T., & Harshman, L. L. (2020). Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: A retrospective international multicenter study. Journal for ImmunoTherapy of Cancer, 8(1), e000538. doi:10.1136/jitc-2020-000538